| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Andreas Festa, Ralph D'Agostino, Russell P Tracy, Steven M Haffne. Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes. vol 51. issue 4. 2002-05-10. PMID:11916936. |
we studied the concentrations of c-reactive protein (crp), fibrinogen, and plasminogen activator inhibitor-1 (pai-1) in 1,047 nondiabetic subjects in relation to incident diabetes within 5 years in the insulin resistance atherosclerosis study. |
2002-05-10 |
2023-08-12 |
human |
| Andreas Festa, Ralph D'Agostino, Russell P Tracy, Steven M Haffne. Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes. vol 51. issue 4. 2002-05-10. PMID:11916936. |
in contrast to pai-1, the association of crp and fibrinogen with incident diabetes was significantly attenuated after adjustment for body fat (bmi or waist circumference) or insulin sensitivity (s(i)), as assessed by a frequently sampled intravenous glucose tolerance test. |
2002-05-10 |
2023-08-12 |
human |
| K Bach-Ngohou, H Nazih, F Nazih-Sanderson, Y Zaïr, D Le Carrer, M Krempf, J M Bar. Negative and independent influence of apolipoprotein E on C-reactive protein (CRP) concentration in obese adults. Potential anti-inflammatory role of apoE in vivo. International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity. vol 25. issue 12. 2002-05-02. PMID:11781754. |
obesity is frequently associated with an increase in the early inflammation marker c-reactive protein (crp), insulin resistance and changes in lipoprotein metabolism. |
2002-05-02 |
2023-08-12 |
Not clear |
| Kenichi Yasunari, Kensaku Maeda, Munehiro Nakamura, Junichi Yoshikaw. Oxidative stress in leukocytes is a possible link between blood pressure, blood glucose, and C-reacting protein. Hypertension (Dallas, Tex. : 1979). vol 39. issue 3. 2002-05-02. PMID:11897762. |
c-reacting protein (crp), insulin action (homeostasis model assessment), and traditional risk factors such as age, gender, body mass index, triglycerides, ldl cholesterol, hdl cholesterol, hemoglobin a(1c), and mean blood pressure were also measured. |
2002-05-02 |
2023-08-12 |
human |
| Gemma Sesmilo, Wesley P Fairfield, Laurence Katznelson, Karen Pulaski, Pamela U Freda, Vivien Bonert, Eleni Dimaraki, Stavros Stavrou, Mary Lee Vance, Douglas Hayden, Anne Klibansk. Cardiovascular risk factors in acromegaly before and after normalization of serum IGF-I levels with the GH antagonist pegvisomant. The Journal of clinical endocrinology and metabolism. vol 87. issue 4. 2002-04-25. PMID:11932303. |
c-reactive protein (crp), il-6, homocysteine, lipoprotein(a), glucose, insulin, triglycerides, total cholesterol, and high-density lipoprotein (hdl) and low-density lipoprotein (ldl) cholesterol were determined at baseline, 4 and 12 wk in the placebo-controlled study and at 3-month intervals (during which igf-i levels were normal) in the longitudinal study. |
2002-04-25 |
2023-08-12 |
Not clear |
| Gemma Sesmilo, Wesley P Fairfield, Laurence Katznelson, Karen Pulaski, Pamela U Freda, Vivien Bonert, Eleni Dimaraki, Stavros Stavrou, Mary Lee Vance, Douglas Hayden, Anne Klibansk. Cardiovascular risk factors in acromegaly before and after normalization of serum IGF-I levels with the GH antagonist pegvisomant. The Journal of clinical endocrinology and metabolism. vol 87. issue 4. 2002-04-25. PMID:11932303. |
in the cross-sectional study, patients had lower crp than did controls [median, 0.3 (range, 0.2-0.8) vs. 2.0 (0.6-3.7) mg/liter; p < 0.0001] and had higher insulin [78.6 (55.8-130.2) vs. 54.5 (36.6-77.5) pm, p = 0.0051]. |
2002-04-25 |
2023-08-12 |
Not clear |
| Gemma Sesmilo, Wesley P Fairfield, Laurence Katznelson, Karen Pulaski, Pamela U Freda, Vivien Bonert, Eleni Dimaraki, Stavros Stavrou, Mary Lee Vance, Douglas Hayden, Anne Klibansk. Cardiovascular risk factors in acromegaly before and after normalization of serum IGF-I levels with the GH antagonist pegvisomant. The Journal of clinical endocrinology and metabolism. vol 87. issue 4. 2002-04-25. PMID:11932303. |
we conclude that patients with active acromegaly have lower crp and higher insulin levels than healthy controls. |
2002-04-25 |
2023-08-12 |
Not clear |
| N G Forouhi, N Sattar, P M McKeigu. Relation of C-reactive protein to body fat distribution and features of the metabolic syndrome in Europeans and South Asians. International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity. vol 25. issue 9. 2002-02-19. PMID:11571595. |
to investigate the association between circulating c-reactive protein (crp) concentrations and indices of body fat distribution and the insulin resistance syndrome in south asians and europeans. |
2002-02-19 |
2023-08-12 |
Not clear |
| G Sesmilo, K K Miller, D Hayden, A Klibansk. Inflammatory cardiovascular risk markers in women with hypopituitarism. The Journal of clinical endocrinology and metabolism. vol 86. issue 12. 2001-12-28. PMID:11739438. |
serum was assayed for crp, il-6, glucose, insulin, igf-i, triglycerides, total cholesterol, low density lipoprotein cholesterol, high density lipoprotein (hdl) cholesterol, lipoprotein(a), e2, total testosterone (total t) and free testosterone (free t), and dehydroepiandrosterone sulfate. |
2001-12-28 |
2023-08-12 |
human |
| A Festa, R D'Agostino, K Williams, A J Karter, E J Mayer-Davis, R P Tracy, S M Haffne. The relation of body fat mass and distribution to markers of chronic inflammation. International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity. vol 25. issue 10. 2001-12-13. PMID:11673759. |
to study the relation of fibrinogen and c-reactive protein (crp) to various measures of body fat and body fat distribution and to investigate whether these relations were explained by differences in insulin sensitivity. |
2001-12-13 |
2023-08-12 |
Not clear |
| N Pannacciulli, F P Cantatore, A Minenna, M Bellacicco, R Giorgino, G De Pergol. C-reactive protein is independently associated with total body fat, central fat, and insulin resistance in adult women. International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity. vol 25. issue 10. 2001-12-13. PMID:11673760. |
to investigate whether c-reactive protein (crp) concentrations are influenced by body composition, insulin resistance, and body fat distribution in healthy women. |
2001-12-13 |
2023-08-12 |
Not clear |
| A R Folsom, J S Pankow, R P Tracy, D K Arnett, J M Peacock, Y Hong, L Djoussé, J H Eckfeld. Association of C-reactive protein with markers of prevalent atherosclerotic disease. The American journal of cardiology. vol 88. issue 2. 2001-08-16. PMID:11448405. |
crp was associated with many other cardiovascular risk factors, particularly markers of obesity and insulin resistance, markers of inflammation and acute phase reaction, and hormone replacement therapy. |
2001-08-16 |
2023-08-12 |
Not clear |
| J C Chambers, S Eda, P Bassett, Y Karim, S G Thompson, J R Gallimore, M B Pepys, J S Koone. C-reactive protein, insulin resistance, central obesity, and coronary heart disease risk in Indian Asians from the United Kingdom compared with European whites. Circulation. vol 104. issue 2. 2001-08-09. PMID:11447077. |
crp values were strongly associated with conventional chd risk factors, measures of obesity, and metabolic disturbances associated with insulin resistance in both racial groups. |
2001-08-09 |
2023-08-12 |
human |
| J C Chambers, S Eda, P Bassett, Y Karim, S G Thompson, J R Gallimore, M B Pepys, J S Koone. C-reactive protein, insulin resistance, central obesity, and coronary heart disease risk in Indian Asians from the United Kingdom compared with European whites. Circulation. vol 104. issue 2. 2001-08-09. PMID:11447077. |
the difference in crp concentrations between indian asians and european whites remained after adjustment for conventional chd risk factors but was eliminated by an adjustment for central obesity and insulin resistance score in asians. |
2001-08-09 |
2023-08-12 |
human |
| I Lemieux, A Pascot, D Prud'homme, N Alméras, P Bogaty, A Nadeau, J Bergeron, J P Despré. Elevated C-reactive protein: another component of the atherothrombotic profile of abdominal obesity. Arteriosclerosis, thrombosis, and vascular biology. vol 21. issue 6. 2001-07-19. PMID:11397704. |
recent studies have suggested that elevated plasma c-reactive protein (crp) levels are associated with the features of insulin resistance syndrome. |
2001-07-19 |
2023-08-12 |
Not clear |
| I Lemieux, A Pascot, D Prud'homme, N Alméras, P Bogaty, A Nadeau, J Bergeron, J P Despré. Elevated C-reactive protein: another component of the atherothrombotic profile of abdominal obesity. Arteriosclerosis, thrombosis, and vascular biology. vol 21. issue 6. 2001-07-19. PMID:11397704. |
in the present study, we have examined the contribution of body composition measured by hydrostatic weighing and of abdominal adipose tissue (at) accumulation assessed by computed tomography to the variation in plasma crp levels associated with atherogenic dyslipidemia of the insulin resistance syndrome in a sample of 159 men, aged 22 to 63 years, covering a wide range of adiposity (body mass index values from 21 to 41 kg/m(2)). |
2001-07-19 |
2023-08-12 |
Not clear |
| I Lemieux, A Pascot, D Prud'homme, N Alméras, P Bogaty, A Nadeau, J Bergeron, J P Despré. Elevated C-reactive protein: another component of the atherothrombotic profile of abdominal obesity. Arteriosclerosis, thrombosis, and vascular biology. vol 21. issue 6. 2001-07-19. PMID:11397704. |
although crp levels were associated with plasma insulin levels measured in the fasting state and after a 75-g oral glucose load, no significant correlations were found with plasma lipoprotein levels. |
2001-07-19 |
2023-08-12 |
Not clear |
| I Lemieux, A Pascot, D Prud'homme, N Alméras, P Bogaty, A Nadeau, J Bergeron, J P Despré. Elevated C-reactive protein: another component of the atherothrombotic profile of abdominal obesity. Arteriosclerosis, thrombosis, and vascular biology. vol 21. issue 6. 2001-07-19. PMID:11397704. |
finally, comparison of body fatness, of abdominal fat accumulation, and of the features of the insulin resistance syndrome across quintiles of crp revealed major differences in body fatness and in indices of abdominal at accumulation between the lowest and the highest crp quintiles, whereas no significant differences were found for variables of the plasma lipoprotein-lipid profile. |
2001-07-19 |
2023-08-12 |
Not clear |
| I Lemieux, A Pascot, D Prud'homme, N Alméras, P Bogaty, A Nadeau, J Bergeron, J P Despré. Elevated C-reactive protein: another component of the atherothrombotic profile of abdominal obesity. Arteriosclerosis, thrombosis, and vascular biology. vol 21. issue 6. 2001-07-19. PMID:11397704. |
these results suggest that obesity and abdominal at accumulation are the critical correlates of elevated plasma crp levels found in men with atherogenic dyslipidemia of the insulin resistance syndrome. |
2001-07-19 |
2023-08-12 |
Not clear |
| C C Kelly, H Lyall, J R Petrie, G W Gould, J M Connell, N Satta. Low grade chronic inflammation in women with polycystic ovarian syndrome. The Journal of clinical endocrinology and metabolism. vol 86. issue 6. 2001-07-05. PMID:11397838. |
log crp correlated with body mass index in both pcos and controls (r = 0.58; p < 0.05 and r = 0.78; p < 0.01, respectively) and inversely with insulin sensitivity (r = -0.57; p < 0.05 and r = -0.69; p < 0.01). |
2001-07-05 |
2023-08-12 |
Not clear |